Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $104.27 USD
Change Today +2.78 / 2.74%
Volume 11.5M
GILD On Other Exchanges
As of 8:10 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robin L. Washington

Chief Financial Officer and Executive Vice President,Gilead Sciences Inc.
AgeTotal Calculated CompensationThis person is connected to 25 board members in 3 different organizations across 7 different industries.

See Board Relationships
As of Fiscal Year 2014


Ms. Robin L. Washington has been the Chief Financial Officer of Gilead Pharmasset LLC since January 17, 2012. Ms. Washington has been the Chief Financial Officer of Gilead Sciences Inc. since May 5, 2008 and its Executive Vice President since January 27, 2013. She has been Chief Financial officer and Senior Vice President at Gilead Palo Alto, Inc. since May 2008. Ms. Washington served as Senior Vice President at Gilead Sciences Inc. from May 5, 2008 to January 27, 2013. ...

Read Full Background

Corporate Headquarters*

333 Lakeside Drive
Foster City, California 94404

United States

Phone: 650-574-3000
Fax: 650-578-9264

Board Members Memberships*

Chief Financial Officer and Director
Independent Director
Director, Member of Audit Committee and Member of Retirement Plans Committee


University of Michigan
Pepperdine University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$797,601

Stock Options*

Restricted Stock Awards$2,504,439
All Other Compensation$8,820
Exercised Options199,148
Exercised Options Value$12,575,924
Exercisable Options4
Exercisable Options Value$215
Unexercisable Options183,218
Unexercisable Options Value$8,665,425
Total Value of Options$21,241,563
Total Number of Options382,370

Total Compensation*

Total Annual Cash Compensation$1,771,671
Total Short Term Compensation$797,601
Other Long Term Compensation$2,513,259
Total Calculated Compensation$6,223,492
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GILD:US $104.27 USD +2.78


Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Allergan plc
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
Olivier Brandicourt Chief Executive Officer and Director
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GILEAD SCIENCES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at